相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Individual participant data meta-analysis of intervention studies with time-to-event outcomes: A review of the methodology and an applied example
Valentijn M. T. de Jong et al.
RESEARCH SYNTHESIS METHODS (2020)
Intermittent Versus Continuous PEG-Asparaginase to Reduce Asparaginase-Associated Toxicities: A NOPHO ALL2008 Randomized Study
Birgitte Klug Albertsen et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Hepatotoxicity during 6-thioguanine treatment in inflammatory bowel disease and childhood acute lymphoblastic leukaemia: A systematic review
Linea Natalie Toksvang et al.
PLOS ONE (2019)
Methotrexate polyglutamate levels and co-distributions in childhood acute lymphoblastic leukemia maintenance therapy
Jacob Nersting et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2019)
DNA-thioguanine nucleotide concentration and relapse-free survival during maintenance therapy of childhood acute lymphoblastic leukaemia (NOPHO ALL2008): a prospective substudy of a phase 3 trial
Stine Nygaard Nielsen et al.
LANCET ONCOLOGY (2017)
Association of Minimal Residual Disease With Clinical Outcome in Pediatric and Adult Acute Lymphoblastic Leukemia AMeta-analysis
Donald A. Berry et al.
JAMA ONCOLOGY (2017)
Measures of 6-mercaptopurine and methotrexate maintenance therapy intensity in childhood acute lymphoblastic leukemia
Stine Nygaard Nielsen et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
Mercaptopurine/Methotrexate Maintenance Therapy of Childhood Acute Lymphoblastic Leukemia: Clinical Facts and Fiction
Kjeld Schmiegelow et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2014)
Second Malignant Neoplasms After Treatment of Childhood Acute Lymphoblastic Leukemia
Kjeld Schmiegelow et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial
Ajay Vora et al.
LANCET ONCOLOGY (2013)
Pneumocystis jiroveci pneumonia prophylaxis during maintenance therapy influences methotrexate/6-mercaptopurine dosing but not event-free survival for childhood acute lymphoblastic leukemia
Mette Levinsen et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2012)
Liquid chromatography-tandem mass spectrometry quantification of 6-thioguanine in DNA using endogenous guanine as internal standard
Jack H. Jacobsen et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2012)
Meta-analysis of randomised trials comparing thiopurines in childhood acute lymphoblastic leukaemia
G. Escherich et al.
LEUKEMIA (2011)
Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study
Valentino Conter et al.
BLOOD (2010)
Acquired resistance to 6-thioguanine in melanoma cells involves the repair enzyme O-6-methylguanine-DNA methyltransferase (MGMT)
Nir Gefen et al.
CANCER BIOLOGY & THERAPY (2010)
Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia
K. Schmiegelow et al.
LEUKEMIA (2010)
Minimal Residual Disease in Acute Lymphoblastic Leukemia
Dario Campana
SEMINARS IN HEMATOLOGY (2009)
Thiopurines in current medical practice: molecular mechanisms and contributions to therapy-related cancer
Peter Karran et al.
NATURE REVIEWS CANCER (2008)
Intensification of mercaptopurine/methotrexate maintenance chemotherapy may increase the risk of relapse for some children with acute lymphoblastic leukemia
K Schmiegelow et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Competitive PCR for quantification of minimal residual disease in acute lymphoblastic leukaemia
C Nyvold et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2000)
分享论文
